By Kamal Choudhury and Christy Santhosh
(Reuters) -The U.S. Food and Drug Administration on Thursday approved Kura Oncology and Japanese partner Kyowa Kirin's once-daily pill, Komzifti, to treat a rare form of blood cancer that has returned or stopped responding to treatment.
The drug is approved for acute myeloid leukemia patients with an NPM1 mutation, a genetic change found in about 30% of cases.
Acute myeloid leukemia is an aggressive cancer of the blood and bone marrow.
Kura said the drug will be available within the next few business days at a price of $48,500 for a one-month supply.
With the approval, Kura's drug now competes with Syndax Pharmaceuticals' Revuforj, which was approved for the same indication by the FDA last month.
Komzifti’s approval comes with a boxed warning for differentiation syndrome and an additional warning for QTc interval prolongation, a delay in the heart’s electrical recovery after a beat, and potential harm to unborn babies.
A boxed warning is the U.S. Food and Drug Administration’s strongest alert for serious or life-threatening risks and appears prominently on a drug’s label to warn doctors and patients.
Revuforj carries a boxed warning for QTc interval prolongation, giving Kura “a significant competitive advantage,” according to Wedbush analysts.
Kura's Chief Medical Officer Mollie Leoni said the risk of QTc prolongation with Komzifti is low, adding it is “extraordinarily unlikely” to lead to a boxed warning.
The company said it is in dialogue with the FDA about potential steps post-approval that could help refine the labeling.
Under the terms of its collaboration with Kyowa, Kura is responsible for manufacturing Komzifti and will lead commercialization in the United States, while Kyowa handles commercial strategy and development outside the U.S.
Analysts, on average, expect Komzifti to have annual sales of $1.32 billion by 2031, according to LSEG data.
(Reporting by Kamal Choudhury and Christy Santhosh in Bengaluru; Editing by Shailesh Kuber and Tasim Zahid)
LATEST POSTS
- 1
The most effective method to Succeed in Your Profession with a Web based Advertising Degree - 2There are thousands of aligned holes in Peru. Archaeologists now think they know who made them
- 3The Most Moving TED Talks You Want to Watch
- 4Moldova says Russian drones violated airspace
- 5Many European nations want Israel to cancel 19 new settlement plans
- Over 250,000 cases of shredded cheese recalled over possible metal fragments
- Elvis Presley's Infamous Pantera Shooting
- Figure out how to Amplify Your Open Record Reward
- College students are now slightly less likely to experience severe depression, research shows – but the mental health crisis is far from over
- Figure out How to Reveal Stowed away Open Record Rewards
- Scientists document a death from a meat allergy tied to certain ticks
- The most effective method to Guarantee Simple Availability in Seniors' SUVs
- Catch the moon dancing with bright star Regulus tonight
- Taylor Swift's 'The End of an Era' docuseries: Everything you need to know, plus how to watch for less
